Michael J Valentino, Dipexium Pharmaceuticals, Inc.'s Executive Chairman and a director of the company, recently acquired 93,295 shares of the company. The buys took place at $0.00 per share (and therefore, likely the result of option or restricted share grants), on April 19, 2017. Valentino now owns 93,295 shares of the company. Valentino operates out of Houston, TX. Some additional info was provided as follows:
Received in exchange for 118,461 shares of common stock of PLx Opco Inc. (formerly PLx Pharma Inc.) in connection with the merger (the "Merger") of PLx Opco Inc. with a wholly owned subsidiary of PLx Pharma Inc. (formerly Dipexium Pharmaceuticals, Inc.).
Received in connection with the Merger in exchange for an employee stock option to buy 142,857 shares of
PLx Opco Inc. common stock for $9.80 per share.
The option is exercisable as to 60,005 shares as of the date hereof, and will become exercisable as to an additional 26,252 shares on each of July 22, 2017 and July 22, 2018 (generally subject to continued employment or consulting relationship through such date).
The above information was disclosed in a filing to the SEC. To see the filing, click here.
To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!
Other recent filings from the company include the following:
General statement of acquisition of beneficial ownership - Nov. 20, 2017
Dipexium Pharmaceuticals, Inc. Just Filed Its Quarterly Report: Loss per share Basic... - Nov. 9, 2017
Departure of Directors or Certain - Oct. 27, 2017